Cheapest Compounded Tirzepatide Providers in 2026: Verified Pricing

Last reviewed: September 10, 2026 Last updated: September 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Mochi Health delivers the lowest advertised entry point—$129/month all-in at the starting tirzepatide dose ($90 medication plus $39 membership)—but doses typically rise within weeks, and Mochi's per-dose model means your monthly bill climbs with your prescription. BrightMeds offers a prepaid three-month rate of $119/month effective ($357 upfront), and AltRx advertises $125/month on a 12-month prepaid plan (promotion captured September 4, 2026, stated to end September 5). Among month-to-month injectable options with flat pricing across all doses, PlexusDx sits at $289 monthly or $249/month on a six-month plan, MEDVi charges $399/month after a $279 first month, and OrderlyMeds bills $299/month after a two-month $299 starter bundle. Below we normalize billing structures, separate introductory rates from refills, and calculate 12-month costs so you can compare like for like.

At-a-glance tirzepatide pricing

This table shows advertised entry prices, standard ongoing monthly rates, and total first-year cost. Figures marked "prepaid effective" are our calculation; all others are provider-stated prices captured September 4–10, 2026.

Note: Prepaid effective rates are our calculation. Mochi's $129 starting-dose figure assumes no dose escalation; most patients titrate upward. AltRx promotion captured September 4, 2026, stated to end September 5. Henry Meds offers oral tirzepatide only; no injectable product. All prices verified or captured September 4–10, 2026.

Normalized like-for-like pricing and 12-month costs

Advertised entry prices often hide refill rates, membership fees, dose-dependent pricing, or prepayment requirements. Below we separate introductory rates from standard monthly charges, add separate fees into all-inclusive totals, and show what twelve months actually costs under each structure.

Mochi Health: lowest entry, per-dose escalation

Mochi advertises tirzepatide starting at $90/month for medication, plus a separate $39 first-month membership fee and $99/month membership thereafter. At the starting dose:

• Month 1: $90 medication + $39 membership = $129 all-in
• Months 2–12: $90 medication + $99 membership = $189/month × 11 = $2,079
• 12-month total: $129 + $2,079 = $2,208 (our calculation)

Mochi uses a per-dose pricing model, so when a provider increases your dose the medication charge rises—captured evidence shows higher doses reaching $199+ for the drug alone, which would push monthly all-in cost to $298+ once membership is added. If you remain at the starting dose for twelve months, Mochi delivers the lowest absolute cost in this comparison. If your dose escalates—the typical path for tirzepatide therapy—your monthly bill climbs accordingly. (Pricing captured September 4, 2026, from Mochi Health checkout; Trustpilot 4.5 stars, ~18,000 reviews, captured September 4, 2026.)

BrightMeds and AltRx: prepaid plans under $130/month effective

BrightMeds offers a three-month tirzepatide plan at $357 total, or $119/month effective (our calculation)—the medication is all-inclusive at any dose. Paying month-to-month costs $149. If you prepay four consecutive three-month cycles, twelve months totals $1,428 (our calculation); at the monthly rate it's $1,788. (Pricing captured September 4, 2026, from BrightMeds public plan grid; brightmeds.com/summer-special.)

AltRx advertises a 12-month prepaid rate of $125/month effective ($1,500 upfront, our calculation), with shorter terms at $130/month for six months, $144/month for three months, and $149 month-to-month. The promotion was stated to end September 5, 2026, when we captured pricing; confirm current availability at checkout. (Pricing captured September 4, 2026, from AltRx promotional grid.)

Both plans require upfront payment and lock you into a fixed term. BrightMeds lets you renew quarterly; AltRx's lowest rate ties up $1,500 for a year. Neither advertises a membership fee.

OrderlyMeds: two-month starter, then $299/month

OrderlyMeds advertises a two-month starter bundle at $299 total, or $149.50/month effective (our calculation), then charges $299/month ongoing. Twelve-month cost:

• Months 1–2: $299 (starter bundle)
• Months 3–12: $299/month × 10 = $2,990
• 12-month total: $299 + $2,990 = $3,289 (our calculation)

No membership fee; all-inclusive pricing. (Pricing captured September 4, 2026; Trustpilot 3.6 stars, ~634 reviews, captured September 4, 2026. Captured one-star Trustpilot reviews report fast charging but slow refunds, non-response, delayed shipping, pharmacy changes, and unwanted calls and texts after opt-out.)

PlexusDx: flat-dose month-to-month or prepaid plans

PlexusDx charges $289/month month-to-month for compounded tirzepatide injection, $269/month on a three-month plan, or $249/month on a six-month plan. Every dose—starting through maintenance—costs the same. No membership fee, no medication upcharge, no visit or shipping fees. Twelve-month cost:

• Month-to-month: $289 × 12 = $3,468 (our calculation)
• Six-month plan: $249 × 12 = $2,988 (our calculation)

You can cancel month-to-month service anytime; prepaid plans require upfront payment for the term. (Pricing captured July 17–23, 2026, and verified September 10, 2026; PlexusDx internal pricing matrix. PlexusDx holds a 4.3-star Trustpilot rating, 79% five-star, 83% four-star or higher, captured September 9, 2026, trustpilot.com/review/plexusdx.com.)

MEDVi: $279 first month, $399 ongoing

MEDVi advertises tirzepatide at $279 for the first month (introductory rate), then $399/month for refills. Twelve-month cost:

• Month 1: $279
• Months 2–12: $399 × 11 = $4,389
• 12-month total: $279 + $4,389 = $4,668 (our calculation)

No membership fee on the compounded pathway (a separate $99/month membership applies to branded Wegovy or Zepbound). Medication, clinician care, unlimited support, and shipping included. (Pricing checkout-verified September 4, 2026; Trustpilot 4.3 stars, ~15,000 reviews, captured September 4, 2026.)

Eden: medication plus membership

Eden charges $199/month for tirzepatide medication and a separate membership fee—$39 the first month, then $99/month. All-in monthly cost:

• Month 1 (introductory rate): $199 medication + $39 membership = $238
• Months 2–12 (standard ongoing rate): $199 medication + $99 membership = $298/month × 11 = $3,278
• 12-month total: $238 + $3,278 = $3,516 (our calculation)

(Pricing captured September 4, 2026; Trustpilot 4.5 stars, ~5,000 reviews, captured September 4, 2026. One captured one-star Trustpilot review reports an 11-day order delay and repeated requests for records Eden had previously issued.)

Found: prepaid annual plans vs. monthly cash

Found offers two payment paths. The cash-pay annual plan charges $2,028 upfront for twelve months of care and compounded tirzepatide—$169/month effective (our calculation)—versus $359/month paying monthly. The insurance-support annual plan charges $1,188 upfront ($99/month effective, our calculation) plus a typical copay around $30/month for branded tirzepatide, versus $199/month plus copay on the monthly plan. The annual plans require full prepayment; the monthly option bills each month. (Pricing captured September 4, 2026, from Found checkout; Trustpilot 4.1 stars, ~732 reviews, captured September 4, 2026.)

Fridays Health and ShedRx: multi-month prepaid discounts

Fridays Health advertises tirzepatide at $359/month standard, with a multi-month prepaid rate of $190/month effective (captured from promotional landing page, September 4, 2026). The provider's product pages and promo pages show conflicting teaser prices; confirm the exact term and total at checkout. Twelve months at the prepaid rate would total approximately $2,280 (our calculation). (Trustpilot 4.2 stars, ~4,700 reviews, captured September 4, 2026.)

ShedRx charges $299/month month-to-month, $269/month effective on a six-month plan, or $239/month effective on a 12-month plan. Twelve-month totals: $3,588 month-to-month, $3,228 on the six-month cycle (our calculation), or $2,868 prepaid annually (our calculation). ShedRx offers injectable and oral tirzepatide formulations; pages contain conflicting teaser prices, so use the product-page rates as the latest verified figures. (Pricing captured September 4, 2026.)

Henry Meds: oral tirzepatide only

Henry Meds does not offer injectable tirzepatide—only an oral dissolving tablet. The three-month oral plan is advertised at $297/month effective under a promotion ($891 upfront), versus a standard total of $1,047 for three months ($349/month effective, our calculation). Copy on the page states "delivered every 60 days for 6 months," an internal inconsistency flagged in our evidence review. Paying the promotional rate four times over twelve months totals $3,564 (our calculation). No membership fee; medication, provider, and shipping are all-inclusive. (Pricing captured September 4, 2026; Trustpilot 4.4 stars, ~13,000 reviews, captured September 4, 2026.)

Other flat-monthly options

Amble: $289/month standard, $329 for higher dose tiers; no membership or shipping fee. FAQ hosted on Canva; recheck totals at direct checkout. (Pricing captured September 4, 2026.)

Embody and Peak Wellness: both $349/month month-to-month; Peak Wellness advertises lower per-month rates on six-month prepaid plans but specifics were not captured. Same price at every dose. (Pricing captured July 17–23, 2026.)

Remedy Meds: $399/month, advertised as "just $9.99/day." No membership or hidden fees claimed. (Pricing captured September 4, 2026; Trustpilot 4.7 displayed during intake.)

Willow: $399/month all-in with free two-day shipping; oral route pricing unitemized. (Pricing captured September 4, 2026.)

Decision factors beyond the monthly price

Dose escalation and per-dose vs. flat models

Tirzepatide therapy typically starts at 2.5 mg weekly and titrates upward every four weeks—2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg. Providers using flat pricing (PlexusDx, OrderlyMeds, MEDVi, BrightMeds, AltRx, ShedRx, Embody, Peak Wellness, Remedy Meds, Willow) charge the same rate whether you take the starting dose or the maximum. Providers using per-dose pricing (Mochi, and to a lesser extent Eden on some plans) raise the monthly medication charge as your dose increases. If you expect to escalate—most patients do—flat pricing offers cost predictability. If you plan maintenance at a lower dose or microdosing after initial therapy, a per-dose model may save money.

Introductory vs. refill rates

MEDVi ($279 first month, $399 ongoing), OrderlyMeds ($149.50 effective for two months, $299 thereafter), and Eden ($238 first month, $298 ongoing) all advertise lower entry prices that rise at refill. Over twelve months the introductory discount dilutes: MEDVi's first-month $120 discount lowers the annual total by 2.6%, OrderlyMeds' two-month starter saves $299 over the year (9% reduction), and Eden's first-month $60 membership discount trims annual cost by 1.7% (our calculations). Compare the twelve-month total, not the headline.

Prepayment requirements and liquidity

BrightMeds, AltRx, Found's annual plans, Fridays' multi-month option, ShedRx's six- and twelve-month plans, and Henry Meds' three-month oral bundles all require upfront payment. AltRx's $1,500 twelve-month plan delivers the second-lowest effective monthly rate ($125) but ties up more cash than BrightMeds' $357 quarterly cycle. Month-to-month plans (PlexusDx $289, Mochi $189+ at starting dose, OrderlyMeds $299 after starter, MEDVi $399, Eden $298, Amble $289, Embody $349, Remedy $399, Willow $399) let you cancel or pause without forfeiting prepaid months.

Oral vs. injectable route

Henry Meds offers oral tirzepatide only—no injectable option. PlexusDx, Eden, and ShedRx offer both routes (PlexusDx oral tirzepatide: $349/month month-to-month, $299 on three-month, $279 on six-month; Eden and ShedRx pricing varies by plan). Oral formulations may suit patients who prefer not to inject, though compounded oral tirzepatide is not FDA-approved and clinical evidence for absorption and efficacy is less mature than for the injectable form. Confirm with your provider whether an oral formulation meets your therapeutic goals.

Service quality and reported issues

Trustpilot ratings range from 3.6 (OrderlyMeds, ~634 reviews) to 4.7 (Remedy Meds, displayed during intake). Captured one-star reviews for OrderlyMeds report fast charging but slow refunds, non-response, delayed shipping, pharmacy changes, and unwanted calls and texts after opt-out (Trustpilot, captured September 4, 2026). A captured Eden one-star review reports an 11-day order delay and repeated requests for records the company had previously issued (Trustpilot, captured September 4, 2026). A captured Mochi one-star review reports a provider appearing late and not engaging (Trustpilot, captured September 4, 2026). These are individual reports and should be read as anecdotes rather than established patterns, but they illustrate the kinds of friction some patients experience. MEDVi (4.3 / ~15,000 reviews), Henry Meds (4.4 / ~13,000 reviews), Mochi (4.5 / ~18,000 reviews), Eden (4.5 / ~5,000 reviews), PlexusDx (4.3 / 79% five-star), Fridays (4.2 / ~4,700 reviews), and Found (4.1 / ~732 reviews) all show volume and ratings that suggest generally consistent service, though no provider is immune to fulfillment or communication gaps.

Choose Mochi if…

You want the lowest absolute entry price, you expect to remain at the starting tirzepatide dose for an extended period, and you accept that your monthly cost will rise if your provider increases your dose. Mochi's $129 all-in first month and $189/month thereafter (at starting dose) beat every flat-rate competitor, but dose escalation is typical in tirzepatide therapy and will push your medication charge—and total monthly bill—higher. Mochi holds a 4.5-star Trustpilot rating across ~18,000 reviews, suggesting reliable service at scale, though one captured review reported a provider appearing late and not engaging. If cost predictability across dose tiers matters more than the lowest possible entry point, a flat-rate plan will serve you better.

Choose BrightMeds or AltRx if…

You can prepay three to twelve months upfront and you want the lowest effective monthly rate. BrightMeds' $119/month three-month cycle ($357 every quarter) and AltRx's $125/month twelve-month plan ($1,500 upfront) sit below every month-to-month option and below Mochi once doses rise. You sacrifice liquidity and month-to-month flexibility, and AltRx's promotion was stated to end September 5, 2026—confirm availability before committing. Both plans include all dose tiers at one price. Neither provider has mature Trustpilot review volume in our captured evidence; service track record is less transparent than higher-volume competitors.

Choose OrderlyMeds if…

You want a flat monthly rate after an affordable two-month onboarding and you accept higher long-term cost in exchange for no prepayment requirement. OrderlyMeds' $299 starter bundle ($149.50/month effective for two months) lowers the barrier, then $299/month ongoing—middle-of-pack among month-to-month flat plans. Over twelve months the total ($3,289) runs higher than PlexusDx six-month ($2,988), Found annual cash ($2,028), ShedRx twelve-month ($2,868), Fridays prepaid (~$2,280), BrightMeds prepaid ($1,428), and AltRx prepaid ($1,500). OrderlyMeds' 3.6-star Trustpilot rating and captured one-star reviews reporting slow refunds, non-response, delayed shipping, and unwanted contact after opt-out raise service-quality questions; weigh the convenience of no long-term commitment against reported friction.

Choose MEDVi if…

You prioritize high-volume service with a strong review record and accept a higher ongoing rate. MEDVi's $279 first month and $399 refill yield a twelve-month total of $4,668—the highest among flat-rate month-to-month injectable plans in this comparison. The 4.3-star Trustpilot rating across ~15,000 reviews signals consistent fulfillment and support at scale, and the platform includes unlimited clinician messaging. If cost is your primary filter, eight other verified options deliver lower annual totals. If reliability and responsive support matter more than price floor, MEDVi's track record justifies the premium.

Choose Found if…

You want an annual prepaid plan with coaching and program structure beyond medication alone, and you can commit $2,028 upfront (cash path) or $1,188 plus copays (insurance path). Found's $169/month effective cash rate sits between BrightMeds/AltRx and the mid-tier month-to-month plans, and the program includes behavioral coaching, food logging, and peer community. The insurance-support path pairs compounded or branded tirzepatide with a lower program fee. Found's 4.1-star Trustpilot rating and ~732 reviews show a smaller volume than MEDVi, Mochi, or Henry Meds; service consistency is less proven at scale. If you want prepaid pricing without the full-year lock of AltRx, Found lets you renew annually rather than committing to a multi-year discounted cycle.

Choose Fridays Health or ShedRx if…

You want multi-month prepaid savings with some term flexibility and you can tolerate pricing page inconsistencies. Fridays' advertised $190/month effective multi-month rate (~$2,280/year) and ShedRx's $239/month twelve-month rate ($2,868/year) both undercut most month-to-month plans and sit above BrightMeds and AltRx but below PlexusDx month-to-month. Both providers' pages show conflicting teaser prices; confirm the exact term, total, and any auto-renewal terms at checkout. Fridays holds a 4.2-star Trustpilot rating (~4,700 reviews); ShedRx review volume was not fully captured. If you prize transparent, conflict-free pricing communication, other options in this range deliver clearer published terms.

Choose Henry Meds if…

You specifically want oral tirzepatide and you accept that Henry Meds does not offer an injectable option. The three-month oral plan at $297/month effective promotional rate ($891 upfront) or $349/month standard ($1,047 for three months) delivers mid-range pricing for the oral route, below PlexusDx oral ($349 month-to-month, $279 six-month) but requiring a three-month prepay. Henry Meds' 4.4-star rating and ~13,000 Trustpilot reviews suggest reliable service. One source inconsistency (copy stating "delivered every 60 days for 6 months" on a three-month product page) raises a documentation-quality question; confirm delivery cadence and refill timing at checkout. If you want injectable tirzepatide, Henry Meds is not an option.

Where PlexusDx fits

PlexusDx holds the middle of the month-to-month flat-rate field—$289/month with no commitment, $249/month on a six-month plan—and delivers the lowest ongoing rate among providers that let you cancel monthly without forfeiting prepaid funds. You pay more per month than Mochi at starting dose ($189 all-in), BrightMeds prepaid ($119 effective), AltRx prepaid ($125 effective), OrderlyMeds after starter ($299), Eden ($298), or Amble ($289), but your price never rises when your dose does, and you avoid the liquidity tie-up of annual prepayment or the service-quality uncertainty of lower-rated or under-reviewed competitors. Over twelve months the six-month plan ($2,988) costs more than BrightMeds ($1,428), AltRx ($1,500), Found annual cash ($2,028), Fridays prepaid (~$2,280), ShedRx twelve-month ($2,868), and Mochi at starting dose ($2,208), and less than PlexusDx month-to-month ($3,468), OrderlyMeds ($3,289), Eden (first month $238 then $298 standard ongoing rate, total $3,516), MEDVi ($4,668), Embody ($4,188), Peak Wellness ($4,188 month-to-month), Remedy ($4,788), and Willow ($4,788). If you titrate to higher doses, the flat model saves money over Mochi's per-dose escalation. If you value flexibility—cancel or pause anytime on month-to-month, or commit six months for $249/month without a year-long lock—PlexusDx sits between ultra-low prepaid floors and higher month-to-month ceilings. The 4.3-star Trustpilot rating (79% five-star, 83% four-star or higher) and transparent single-line pricing (medication, visits, labs, shipping all included, no membership) make the cost and service picture clear before you start.

Methodology and freshness

We captured pricing from provider checkouts, public plan grids, and product pages between July 17 and September 10, 2026. Every price in the comparison tables is provider-stated or, where labeled, our calculation (12-month totals, prepaid effective monthly rates, all-in costs that combine medication and membership). Trustpilot ratings and review volumes were captured September 4–9, 2026, from each provider's Trustpilot profile. Where checkout totals conflicted with advertised teaser prices, we used the checkout figure and noted the conflict. Promotional rates (MEDVi first month, OrderlyMeds starter, Eden first month, BrightMeds three-month, AltRx twelve-month, Found annual, Fridays multi-month, ShedRx six- and twelve-month, Henry Meds three-month) are labeled as introductory, starter, or prepaid effective and appear alongside standard ongoing or refill rates. Mochi's starting-dose cost assumes no dose escalation; real-world therapy typically requires titration. Review themes are paraphrased from individual Trustpilot one-star reports and presented as anecdotal examples, not as verified patterns or established facts. No provider paid for inclusion or favorable placement. We re-verify pricing quarterly and flag any conflicts or ambiguities we cannot resolve at checkout.

Frequently Asked Questions

Which compounded tirzepatide provider has the lowest monthly price?

Mochi Health starts at $129 all-in the first month and $189/month thereafter at the starting dose, the lowest ongoing rate if you remain at that dose. BrightMeds ($119/month effective on three-month prepay) and AltRx ($125/month effective on twelve-month prepay) offer lower effective rates but require upfront payment and lock you into a fixed term. Mochi uses per-dose pricing, so your cost rises when your provider increases your prescription—most tirzepatide patients titrate upward within weeks.

Do cheaper tirzepatide plans require long-term contracts or prepayment?

The lowest effective monthly rates—BrightMeds $119, AltRx $125, Found cash annual $169, Fridays multi-month $190, ShedRx twelve-month $239—all require prepaying three to twelve months. Month-to-month plans with no prepayment start at $189 (Mochi starting dose), $249 (PlexusDx six-month with monthly billing), $289 (PlexusDx and Amble month-to-month), $298 (Eden after first month), and $299 (OrderlyMeds after two-month starter). You trade upfront cost and commitment for a lower effective rate.

How much does tirzepatide cost over a full year including introductory rates?

Twelve-month totals range from $1,428 (BrightMeds three-month prepaid × 4) and $1,500 (AltRx twelve-month prepaid) at the low end to $4,788 (Remedy Meds, Willow) at the high end. PlexusDx six-month runs $2,988, month-to-month $3,468. Mochi at starting dose totals $2,208 but rises with dose escalation. MEDVi totals $4,668, OrderlyMeds $3,289, Eden $3,516. Introductory discounts (MEDVi $279 first month, OrderlyMeds $299 two-month starter, Eden $238 first month) lower annual cost by 2–9% over the standard rate.

What is the difference between per-dose and flat-rate tirzepatide pricing?

Flat-rate plans (PlexusDx, BrightMeds, AltRx, OrderlyMeds, MEDVi, ShedRx, Embody, Peak Wellness, Remedy, Willow) charge the same monthly price whether you take 2.5 mg or 15 mg weekly. Per-dose plans (Mochi, some Eden tiers) start cheaper but raise the medication charge each time your provider increases your dose. Flat pricing offers cost predictability; per-dose pricing rewards patients who stabilize at lower doses or switch to maintenance microdosing after initial therapy. Most patients titrate tirzepatide upward over three to six months.

Are compounded tirzepatide medications FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies. Branded Mounjaro and Zepbound are FDA-approved tirzepatide products; compounded tirzepatide is not the same drug and has not undergone the same regulatory review for safety, efficacy, or manufacturing quality.

Sources

• PlexusDx pricing matrix (internal, verified 2026-09-10) and product pages (captured 2026-07-17–23)
• MEDVi checkout verification (captured 2026-09-04, medvi.com)
• Henry Meds product pages (captured 2026-09-04, henrymeds.com)
• Eden checkout and product pages (captured 2026-09-04, edenrx.com)
• OrderlyMeds promotional grid (captured 2026-09-04, orderlymeds.com)
• Mochi Health checkout (captured 2026-09-04, mochihealth.com)
• BrightMeds public plan grid (captured 2026-09-04, brightmeds.com/summer-special)
• AltRx promotional grid (captured 2026-09-04, altrx.com)
• Found checkout (captured 2026-09-04, foundhealthcare.com)
• Fridays Health promotional landing page (captured 2026-09-04, fridayshealth.com)
• ShedRx product pages (captured 2026-09-04, shedrx.com)
• Amble FAQ (captured 2026-09-04, amblehealth.com)
• Embody and Peak Wellness product pages (captured 2026-07-17–23)
• Remedy Meds checkout (captured 2026-09-04, remedymeds.com)
• Willow pricing page (captured 2026-09-04, willowhealth.com)
• Trustpilot reviews for PlexusDx (captured 2026-09-09, trustpilot.com/review/plexusdx.com), MEDVi, Henry Meds, Eden, OrderlyMeds, Mochi, Found, Fridays, Remedy (all captured 2026-09-04)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.